← Evidence map

ArticleHeliyon2023

A two-step purification platform for efficient removal of Fab-related impurities: A case study for Ranibizumab.

Ozge Tatli et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.

4 papers cite it

2023
2024
2025
2026
this papercites it
Full record →Abstract, authors, funding and every citing paper · PMID 38027967